Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS)
Abstract Background Adolescent-onset psychosis is associated with more severe symptoms and poorer outcomes than adult-onset psychosis. The National Institute for Clinical Excellence (NICE) recommend that adolescents with first episode psychosis (FEP) should be offered a combination of antipsychotic...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-07-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-019-3506-1 |
id |
doaj-9d96b2895d2f4f1b9adf5bb69843ceb7 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Melissa Pyle Matthew R. Broome Emmeline Joyce Graeme MacLennan John Norrie Daniel Freeman David Fowler Peter M. Haddad David Shiers Chris Hollis Jo Smith Ashley Liew Rory E. Byrne Paul French Sarah Peters Jemma Hudson Linda Davies Richard Emsley Alison Yung Max Birchwood Eleanor Longden Anthony P. Morrison |
spellingShingle |
Melissa Pyle Matthew R. Broome Emmeline Joyce Graeme MacLennan John Norrie Daniel Freeman David Fowler Peter M. Haddad David Shiers Chris Hollis Jo Smith Ashley Liew Rory E. Byrne Paul French Sarah Peters Jemma Hudson Linda Davies Richard Emsley Alison Yung Max Birchwood Eleanor Longden Anthony P. Morrison Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS) Trials First-episode psychosis Cognitive behavioural therapy Family intervention Psychological intervention Antipsychotic medication Adolescent psychosis |
author_facet |
Melissa Pyle Matthew R. Broome Emmeline Joyce Graeme MacLennan John Norrie Daniel Freeman David Fowler Peter M. Haddad David Shiers Chris Hollis Jo Smith Ashley Liew Rory E. Byrne Paul French Sarah Peters Jemma Hudson Linda Davies Richard Emsley Alison Yung Max Birchwood Eleanor Longden Anthony P. Morrison |
author_sort |
Melissa Pyle |
title |
Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS) |
title_short |
Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS) |
title_full |
Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS) |
title_fullStr |
Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS) |
title_full_unstemmed |
Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS) |
title_sort |
study protocol for a randomised controlled trial of cbt vs antipsychotics vs both in 14–18-year-olds: managing adolescent first episode psychosis: a feasibility study (maps) |
publisher |
BMC |
series |
Trials |
issn |
1745-6215 |
publishDate |
2019-07-01 |
description |
Abstract Background Adolescent-onset psychosis is associated with more severe symptoms and poorer outcomes than adult-onset psychosis. The National Institute for Clinical Excellence (NICE) recommend that adolescents with first episode psychosis (FEP) should be offered a combination of antipsychotic medication (APs), cognitive behavioural therapy (CBT) and family intervention (FI). The evidence for APs in treating psychosis is limited in adolescents compared to adults. Nevertheless, it indicates that APs can reduce overall symptoms in adolescents but may cause more severe side effects, including cardiovascular and metabolic effects, than in adults. CBT and FI can improve outcomes in adults, but there are no studies of psychological interventions (PI) in patients under 18 years old. Given this limited evidence base, NICE made a specific research recommendation for determining the clinical and cost effectiveness of APs versus PI versus both treatments for adolescent FEP. Methods/design The current study aimed to establish the feasibility and acceptability of conducting such a trial by recruiting 14–18-year-olds with a first episode of psychosis into a feasibility prospective randomised open blinded evaluation (PROBE) design, three-arm, randomised controlled trial of APs alone versus PI alone versus a combination of both treatments. We aimed to recruit 90 participants from Early Intervention and Child and Adolescent Mental Health Teams in seven UK sites. APs were prescribed by participants’ usual psychiatrists. PI comprised standardised cognitive behavioural therapy and family intervention sessions. Discussion This is the first study to compare APs to PI in an adolescent population with FEP. Recruitment finished on 31 October 2018. The study faced difficulties with recruitment across most sites due to factors including clinician and service-user treatment preferences. Trial registration Current controlled trial with ISRCTN, ISRCTN80567433. Registered on 27 February 2017. |
topic |
First-episode psychosis Cognitive behavioural therapy Family intervention Psychological intervention Antipsychotic medication Adolescent psychosis |
url |
http://link.springer.com/article/10.1186/s13063-019-3506-1 |
work_keys_str_mv |
AT melissapyle studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT matthewrbroome studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT emmelinejoyce studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT graememaclennan studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT johnnorrie studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT danielfreeman studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT davidfowler studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT petermhaddad studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT davidshiers studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT chrishollis studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT josmith studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT ashleyliew studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT roryebyrne studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT paulfrench studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT sarahpeters studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT jemmahudson studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT lindadavies studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT richardemsley studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT alisonyung studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT maxbirchwood studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT eleanorlongden studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps AT anthonypmorrison studyprotocolforarandomisedcontrolledtrialofcbtvsantipsychoticsvsbothin1418yearoldsmanagingadolescentfirstepisodepsychosisafeasibilitystudymaps |
_version_ |
1724670782423957504 |
spelling |
doaj-9d96b2895d2f4f1b9adf5bb69843ceb72020-11-25T03:07:24ZengBMCTrials1745-62152019-07-0120111310.1186/s13063-019-3506-1Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS)Melissa Pyle0Matthew R. Broome1Emmeline Joyce2Graeme MacLennan3John Norrie4Daniel Freeman5David Fowler6Peter M. Haddad7David Shiers8Chris Hollis9Jo Smith10Ashley Liew11Rory E. Byrne12Paul French13Sarah Peters14Jemma Hudson15Linda Davies16Richard Emsley17Alison Yung18Max Birchwood19Eleanor Longden20Anthony P. Morrison21The Psychosis Research Unit, Department of Psychology, Greater Manchester Mental Health NHS Foundation TrustInstitute for Mental Health, School of Psychology, University of BirminghamThe Psychosis Research Unit, Department of Psychology, Greater Manchester Mental Health NHS Foundation TrustCentre for Healthcare Randomised Trials, Health Services Research Unit, University of AberdeenEdinburgh Clinical Trials Unit, Centre for Population Health Sciences, Usher Institute, Nine Edinburgh BioQuarterDepartment of Psychiatry, Medical Sciences Division, University of Oxford, Warneford HospitalSchool of Psychology, Pevensey Building, University of SussexThe Psychosis Research Unit, Department of Psychology, Greater Manchester Mental Health NHS Foundation TrustThe Psychosis Research Unit, Department of Psychology, Greater Manchester Mental Health NHS Foundation TrustNIHR MindTech MedTech Co-operative, Division of Psychiatry and Applied Psychology, Institute of Mental Health, University of NottinghamSchool of Allied Health and Community, Bredon Building, University of WorcesterInstitute for Mental Health, School of Psychology, University of BirminghamThe Psychosis Research Unit, Department of Psychology, Greater Manchester Mental Health NHS Foundation TrustThe Psychosis Research Unit, Department of Psychology, Greater Manchester Mental Health NHS Foundation TrustDivision of Psychology and Mental Health, University of ManchesterCentre for Healthcare Randomised Trials, Health Services Research Unit, University of AberdeenDivision of Population Health, Health Services Research & Primary Care, University of ManchesterDepartment of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology & Neuroscience, King’s College LondonThe Psychosis Research Unit, Department of Psychology, Greater Manchester Mental Health NHS Foundation TrustWarwick Medical School-Mental Health and Wellbeing, University of WarwickThe Psychosis Research Unit, Department of Psychology, Greater Manchester Mental Health NHS Foundation TrustThe Psychosis Research Unit, Department of Psychology, Greater Manchester Mental Health NHS Foundation TrustAbstract Background Adolescent-onset psychosis is associated with more severe symptoms and poorer outcomes than adult-onset psychosis. The National Institute for Clinical Excellence (NICE) recommend that adolescents with first episode psychosis (FEP) should be offered a combination of antipsychotic medication (APs), cognitive behavioural therapy (CBT) and family intervention (FI). The evidence for APs in treating psychosis is limited in adolescents compared to adults. Nevertheless, it indicates that APs can reduce overall symptoms in adolescents but may cause more severe side effects, including cardiovascular and metabolic effects, than in adults. CBT and FI can improve outcomes in adults, but there are no studies of psychological interventions (PI) in patients under 18 years old. Given this limited evidence base, NICE made a specific research recommendation for determining the clinical and cost effectiveness of APs versus PI versus both treatments for adolescent FEP. Methods/design The current study aimed to establish the feasibility and acceptability of conducting such a trial by recruiting 14–18-year-olds with a first episode of psychosis into a feasibility prospective randomised open blinded evaluation (PROBE) design, three-arm, randomised controlled trial of APs alone versus PI alone versus a combination of both treatments. We aimed to recruit 90 participants from Early Intervention and Child and Adolescent Mental Health Teams in seven UK sites. APs were prescribed by participants’ usual psychiatrists. PI comprised standardised cognitive behavioural therapy and family intervention sessions. Discussion This is the first study to compare APs to PI in an adolescent population with FEP. Recruitment finished on 31 October 2018. The study faced difficulties with recruitment across most sites due to factors including clinician and service-user treatment preferences. Trial registration Current controlled trial with ISRCTN, ISRCTN80567433. Registered on 27 February 2017.http://link.springer.com/article/10.1186/s13063-019-3506-1First-episode psychosisCognitive behavioural therapyFamily interventionPsychological interventionAntipsychotic medicationAdolescent psychosis |